MARY ISABEL SALAZAR
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health SAN ANTONIO, TX NPI 1962592154
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health TX Exelixis Inc. All categories
General Payments — all program years on this page
$48,739.59
- Category: General Payments
- Program years: PY2021–2024
- Record count: 163
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $32,290.23 across 100 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $11,996.97 | 56 |
| Compensation for serving as faculty or as a speaker for a medical education program | $10,370.00 | 4 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,830.00 | 7 |
| Food and Beverage | $1,553.26 | 32 |
| Consulting Fee | $540.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Exelixis Inc. | $18,852.78 | 57 |
| Incyte Corporation | $12,568.02 | 36 |
| Fresenius Kabi USA, LLC | $582.34 | 2 |
| Astellas Pharma US Inc | $147.63 | 1 |
| Acerta Pharma LLC | $90.36 | 1 |
| Iovance Biotherapeutics, Inc. | $21.35 | 1 |
| Celgene Corporation | $14.46 | 1 |
| Agios Pharmaceuticals, Inc. | $13.29 | 1 |
By program year
Records — PY2024 (100)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.